Metraipolis › archive › dc_a8ca79767654

A single-center retrospective study of dabrafenib plus trametinib combination therapy in patients with BRAF V600E-positive thyroid cancer — Europe PMC PMID:40844731

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40844731
DOI
10.1007/s10147-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-10T10:23:38.107Z
SHA-256 of the archived text
9bded90c69ec5d32648be1b482dbb99da07b6a4001ee92518d00e9873bb48439
Stable URL of this page
https://metraipolis.com/documento/dc_a8ca79767654

How to cite

A single-center retrospective study of dabrafenib plus trametinib combination therapy in patients with BRAF V600E-positive thyroid cancer — Europe PMC PMID:40844731 — Europe PMC (en), https://europepmc.org/article/MED/40844731 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a8ca79767654 (Metraipolis archive dc_a8ca79767654, sha256 9bded90c69ec5d32648be1b482dbb99da07b6a4001ee92518d00e9873bb48439)
BibTeX
@misc{dca8ca79767654,
  title = {A single-center retrospective study of dabrafenib plus trametinib combination therapy in patients with BRAF V600E-positive thyroid cancer — Europe PMC PMID:40844731},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40844731},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a8ca79767654; sha256 9bded90c69ec5d32648be1b482dbb99da07b6a4001ee92518d00e9873bb48439},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40844731. Agents can read the archived copy with the MCP tool read_document.